Pengfei Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Pengfei Liu has a total of 924 co-authors. Here are the top co-authors by number of shared publications:
- Jill A. Rosenfeld
Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA
19 shared publications - Jennifer E. Posey
Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, 77030, USA
11 shared publications Weimin Bi
Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas 77030, USA
11 shared publicationsChristine Eng
Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA; Medical Genetics and Multiomics Laboratory, Baylor College of Medicine, Houston, TX 77030, USA; Baylor Genetics, Houston, TX 77021, USA
9 shared publicationsHongzheng Dai
Department of Molecular and Human Genetics Baylor College of Medicine Houston Texas USA
9 shared publicationsJill A. Rosenfeld
Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA
9 shared publications
Latest Publications
- 25 October 2026
- Published by SAGE Publications in Nucleic Acid Therapeutics
Considerations of Gene Expression Analysis Methods for Gapmer Antisense Oligonucleotide-Treated Samples
Probe-based PCR assays are commonly used to evaluate gene expression in antisense oligonucleotide (ASO)-treated samples, but assay design and postextraction processing may introduce substantial measurement bias. We investigated workflow-dependent differences in measured knockdown across PCR-based and RNA-sequencing assays using an allele-specific gapmer ASO, targeting a linked single nucleotide polymorphism of a dominant-negative SPTAN1 variant. Exogenous ribonuclease H (RNase H) activity during reverse transcription or ribosomal RNA (rRNA)-depletion inflated apparent knockdown and reduced RNA-sequencing coverage at the ASO-binding site. In droplet digital PCR (ddPCR), allele-specific detection probes overlapping the ASO-binding site produced substantially greater apparent knockdown than nonoverlapping probes, particularly following workflows with active RNase H. Spike-in experiments showed that this bias was not reproduced by adding ASO to purified RNA before complementary DNA (cDNA) synthesis or to cDNA before ddPCR, but emerged when ASO was present during rRNA depletion. Together, these findings show that exogenous RNase H activity during RNA processing and ASO–probe overlap can distort measurements of gapmer-mediated transcript reduction. Poly(A)-based RNA sequencing, reverse transcriptase with reduced RNase H activity, and nonoverlapping PCR detection probes can minimize measurement bias when evaluating gapmer ASO-mediated knockdown.
- 25 October 2026
- Published by SAGE Publications in Nucleic Acid Therapeutics
Considerations of Gene Expression Analysis Methods for Gapmer Antisense Oligonucleotide-Treated Samples
Probe-based PCR assays are commonly used to evaluate gene expression in antisense oligonucleotide (ASO)-treated samples, but assay design and postextraction processing may introduce substantial measurement bias. We investigated workflow-dependent differences in measured knockdown across PCR-based and RNA-sequencing assays using an allele-specific gapmer ASO, targeting a linked single nucleotide polymorphism of a dominant-negative SPTAN1 variant. Exogenous ribonuclease H (RNase H) activity during reverse transcription or ribosomal RNA (rRNA)-depletion inflated apparent knockdown and reduced RNA-sequencing coverage at the ASO-binding site. In droplet digital PCR (ddPCR), allele-specific detection probes overlapping the ASO-binding site produced substantially greater apparent knockdown than nonoverlapping probes, particularly following workflows with active RNase H. Spike-in experiments showed that this bias was not reproduced by adding ASO to purified RNA before complementary DNA (cDNA) synthesis or to cDNA before ddPCR, but emerged when ASO was present during rRNA depletion. Together, these findings show that exogenous RNase H activity during RNA processing and ASO–probe overlap can distort measurements of gapmer-mediated transcript reduction. Poly(A)-based RNA sequencing, reverse transcriptase with reduced RNase H activity, and nonoverlapping PCR detection probes can minimize measurement bias when evaluating gapmer ASO-mediated knockdown.
- Open Access
Paralemmin 2 is a shared, alternatively-spliced regulator of axon initial segments and paranodal junctions in oligodendrocytes
Nervous system function depends on highly specialized axonal membrane domains. For example, axon initial segments (AIS), nodes of Ranvier, and paranodal junctions are essential for action potential initiation and saltatory conduction. These domains use shared molecular machinery converging on the master scaffolding protein AnkyrinG (AnkG). Using endogenous AnkG-TurboID proximity proteomics, we identify Paralemmin 2 (Palm2), a previously uncharacterized CNS protein, as a shared component of the AIS and nodes of Ranvier in neurons, and paranodes in oligodendrocytes. Palm2 localizes transiently to the AIS and nodes during development, but is found at paranodes throughout life, reflecting cell type-specific splicing of a lipid-modified domain both necessary and sufficient for AnkG interaction. Mice lacking oligodendroglial Palm2 assemble normal paranodes during development, but aged mice lose paranode integrity due to loss of paranodal AnkG and Neurofascin-155. Our findings identify Palm2 as a lipid raft-associated regulator of axonal and oligodendroglial membrane domains and reveal cell type-specific protein variants as a recurring principle for specializing axonal and glial membrane architectures.
Open AccessParalemmin 2 is a shared, alternatively-spliced regulator of axon initial segments and paranodal junctions in oligodendrocytes
Nervous system function depends on highly specialized axonal membrane domains. For example, axon initial segments (AIS), nodes of Ranvier, and paranodal junctions are essential for action potential initiation and saltatory conduction. These domains use shared molecular machinery converging on the master scaffolding protein AnkyrinG (AnkG). Using endogenous AnkG-TurboID proximity proteomics, we identify Paralemmin 2 (Palm2), a previously uncharacterized CNS protein, as a shared component of the AIS and nodes of Ranvier in neurons, and paranodes in oligodendrocytes. Palm2 localizes transiently to the AIS and nodes during development, but is found at paranodes throughout life, reflecting cell type-specific splicing of a lipid-modified domain both necessary and sufficient for AnkG interaction. Mice lacking oligodendroglial Palm2 assemble normal paranodes during development, but aged mice lose paranode integrity due to loss of paranodal AnkG and Neurofascin-155. Our findings identify Palm2 as a lipid raft-associated regulator of axonal and oligodendroglial membrane domains and reveal cell type-specific protein variants as a recurring principle for specializing axonal and glial membrane architectures.
- Open Access
- 9 April 2026
- Published by Wiley in Prenatal Diagnosis
- Vol. 46 (8) , 1140-1150
Evaluating the Utility of RNAseq in Prenatal Diagnostics: Expression Profiles of Cultured Chorionic Villus and Amniotic Fluid Samples
Objective: While RNAseq has enhanced variant interpretation in postnatal cases, its potential in the prenatal setting remains underexplored. This study investigates the utility of RNAseq in prenatal diagnostics by analyzing the expression profiles of cultured chorionic villus samples (cCVS) and amniotic fluid (cAF) samples. Methods: We performed RNAseq on 25 prenatal samples (10 cCVS and 15 cAF) and compared their expression profiles with those of postnatal tissues—blood and skin fibroblasts. Results: To evaluate the clinical relevance of gene expression in these samples, we curated a list of genes associated with fetal‐onset genetic disorders ( n = 375). Using this curated list as a reference, our analysis revealed that cAF samples have the highest proportion of highly expressed genes (60%), surpassing cCVS (54%), fibroblasts (54%), and blood (34%). Differential expression analysis identified unique gene expression patterns in cCVS and cAF samples, reflecting their distinct tissue origins. Specifically, cAF samples showed elevated expression of genes involved in fetal kidney development, whereas cCVS samples were enriched for genes related to trophoblast function. Conclusions: These findings demonstrate that prenatal RNAseq reliably detects clinically relevant gene expressions, offering insights into prenatal conditions and fetal organ development. This underscores the potential of prenatal RNAseq as a valuable tool for supporting genetic variant interpretation.
- 9 April 2026
- Published by Wiley in Prenatal Diagnosis
- Vol. 46 (8) , 1140-1150
Open AccessEvaluating the Utility of RNAseq in Prenatal Diagnostics: Expression Profiles of Cultured Chorionic Villus and Amniotic Fluid Samples
Objective: While RNAseq has enhanced variant interpretation in postnatal cases, its potential in the prenatal setting remains underexplored. This study investigates the utility of RNAseq in prenatal diagnostics by analyzing the expression profiles of cultured chorionic villus samples (cCVS) and amniotic fluid (cAF) samples. Methods: We performed RNAseq on 25 prenatal samples (10 cCVS and 15 cAF) and compared their expression profiles with those of postnatal tissues—blood and skin fibroblasts. Results: To evaluate the clinical relevance of gene expression in these samples, we curated a list of genes associated with fetal‐onset genetic disorders ( n = 375). Using this curated list as a reference, our analysis revealed that cAF samples have the highest proportion of highly expressed genes (60%), surpassing cCVS (54%), fibroblasts (54%), and blood (34%). Differential expression analysis identified unique gene expression patterns in cCVS and cAF samples, reflecting their distinct tissue origins. Specifically, cAF samples showed elevated expression of genes involved in fetal kidney development, whereas cCVS samples were enriched for genes related to trophoblast function. Conclusions: These findings demonstrate that prenatal RNAseq reliably detects clinically relevant gene expressions, offering insights into prenatal conditions and fetal organ development. This underscores the potential of prenatal RNAseq as a valuable tool for supporting genetic variant interpretation.
- 10 October 2025
- Published by Elsevier in The American Journal of Human Genetics
- Vol. 112 (11) , 2578-2590
The utility of ultra-deep RNA sequencing in Mendelian disorder diagnostics
- 10 October 2025
- Published by Elsevier in The American Journal of Human Genetics
- Vol. 112 (11) , 2578-2590
The utility of ultra-deep RNA sequencing in Mendelian disorder diagnostics
- 27 May 2025
- Published by Wiley in Prenatal Diagnosis
- Vol. 45 (10) , 1313-1324
Diagnostic Yield of Exome Sequencing for Pregnancies With and Without Fetal Anomalies and for Stillbirth
Objective: Exome sequencing (ES) benefits the genetic work‐up for fetuses with structural anomalies, but data on its utility for fetuses without anomalies and stillbirths is more limited. We report our experience with prenatal ES for all three indications.Method: We retrospectively reviewed results from 344 trio‐ES performed for fetuses with structural anomalies (N = 262), stillbirths (N = 39), and fetuses without anomalies (N = 43), many of which had a relevant family history. We classified pathogenic variants (P), likely pathogenic variants (LP), or variants of uncertain significance (VUS) favoring pathogenicity in a gene consistent with the fetal phenotype as diagnostic results. We used Fisher's exact test for statistical analysis.Results: Trio‐ES provided a diagnosis for 93/262 (35.5%) fetuses with structural anomalies, with comparable yields for multiple and single anomalies (p = 0.81). A molecular diagnosis was made for 10/39 stillbirths (25.6%), of which all but one had structural anomalies, and 66.6% had multiple anomalies. In the absence of structural anomalies, one of 43 fetuses (2.3%) was found to have compound heterozygous pathogenic variants in ORC6 associated with Meier‐Gorlin syndrome.Conclusion: Prenatal trio‐ES yields molecular diagnoses across a spectrum of indications. Larger studies are needed to further define the added benefits and challenges of diagnostic ES for fetuses without anomalies.
- 27 May 2025
- Published by Wiley in Prenatal Diagnosis
- Vol. 45 (10) , 1313-1324
Diagnostic Yield of Exome Sequencing for Pregnancies With and Without Fetal Anomalies and for Stillbirth
Objective: Exome sequencing (ES) benefits the genetic work‐up for fetuses with structural anomalies, but data on its utility for fetuses without anomalies and stillbirths is more limited. We report our experience with prenatal ES for all three indications.Method: We retrospectively reviewed results from 344 trio‐ES performed for fetuses with structural anomalies (N = 262), stillbirths (N = 39), and fetuses without anomalies (N = 43), many of which had a relevant family history. We classified pathogenic variants (P), likely pathogenic variants (LP), or variants of uncertain significance (VUS) favoring pathogenicity in a gene consistent with the fetal phenotype as diagnostic results. We used Fisher's exact test for statistical analysis.Results: Trio‐ES provided a diagnosis for 93/262 (35.5%) fetuses with structural anomalies, with comparable yields for multiple and single anomalies (p = 0.81). A molecular diagnosis was made for 10/39 stillbirths (25.6%), of which all but one had structural anomalies, and 66.6% had multiple anomalies. In the absence of structural anomalies, one of 43 fetuses (2.3%) was found to have compound heterozygous pathogenic variants in ORC6 associated with Meier‐Gorlin syndrome.Conclusion: Prenatal trio‐ES yields molecular diagnoses across a spectrum of indications. Larger studies are needed to further define the added benefits and challenges of diagnostic ES for fetuses without anomalies.
- Open Access
- 29 April 2025
- Published by eLife Sciences Publications, Ltd in eLife preprints
- Vol. 13
EPHA4 signaling dysregulation links abnormal locomotion and the development of idiopathic scoliosis
Idiopathic scoliosis (IS) is the most common form of spinal deformity with unclear pathogenesis. In this study, we firstly reanalyzed the loci associated with IS, drawing upon previous studies. Subsequently, we mapped these loci to candidate genes using either location-based or function-based strategies. To further substantiate our findings, we verified the enrichment of variants within these candidate genes across several large IS cohorts encompassing Chinese, East Asian, and European populations. Consequently, we identified variants in the EPHA4 gene as compelling candidates for IS. To confirm their pathogenicity, we generated zebrafish mutants of epha4a. Remarkably, the zebrafish epha4a mutants exhibited pronounced scoliosis during later stages of development, effectively recapitulating the IS phenotype. We observed that the epha4a mutants displayed defects in left-right coordination during locomotion, which arose from disorganized neural activation in these mutants. Our subsequent experiments indicated that the disruption of the central pattern generator (CPG) network, characterized by abnormal axon guidance of spinal cord interneurons, contributed to the disorganization observed in the mutants. Moreover, when knocked down efnb3b, the ligand for Epha4a, we observed similar CPG defects and disrupted left-right locomotion. These findings strongly suggested that ephrin B3-Epha4 signaling is vital for the proper functioning of CPGs, and defects in this pathway could lead to scoliosis in zebrafish. Furthermore, we identified two cases of IS in NGEF, a downstream molecule in the EPHA4 pathway. Collectively, our data provide compelling evidence that neural patterning impairments and disruptions in CPGs may underlie the pathogenesis of IS.
- 29 April 2025
- Published by eLife Sciences Publications, Ltd in eLife preprints
- Vol. 13
Open AccessEPHA4 signaling dysregulation links abnormal locomotion and the development of idiopathic scoliosis
Idiopathic scoliosis (IS) is the most common form of spinal deformity with unclear pathogenesis. In this study, we firstly reanalyzed the loci associated with IS, drawing upon previous studies. Subsequently, we mapped these loci to candidate genes using either location-based or function-based strategies. To further substantiate our findings, we verified the enrichment of variants within these candidate genes across several large IS cohorts encompassing Chinese, East Asian, and European populations. Consequently, we identified variants in the EPHA4 gene as compelling candidates for IS. To confirm their pathogenicity, we generated zebrafish mutants of epha4a. Remarkably, the zebrafish epha4a mutants exhibited pronounced scoliosis during later stages of development, effectively recapitulating the IS phenotype. We observed that the epha4a mutants displayed defects in left-right coordination during locomotion, which arose from disorganized neural activation in these mutants. Our subsequent experiments indicated that the disruption of the central pattern generator (CPG) network, characterized by abnormal axon guidance of spinal cord interneurons, contributed to the disorganization observed in the mutants. Moreover, when knocked down efnb3b, the ligand for Epha4a, we observed similar CPG defects and disrupted left-right locomotion. These findings strongly suggested that ephrin B3-Epha4 signaling is vital for the proper functioning of CPGs, and defects in this pathway could lead to scoliosis in zebrafish. Furthermore, we identified two cases of IS in NGEF, a downstream molecule in the EPHA4 pathway. Collectively, our data provide compelling evidence that neural patterning impairments and disruptions in CPGs may underlie the pathogenesis of IS.
- 4 March 2025
- Published by Elsevier in The American Journal of Human Genetics
- Vol. 112 (4) , 779-792
Clinical validation of RNA sequencing for Mendelian disorder diagnostics
- 4 March 2025
- Published by Elsevier in The American Journal of Human Genetics
- Vol. 112 (4) , 779-792
Clinical validation of RNA sequencing for Mendelian disorder diagnostics
- Open Access
- 17 February 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-24
RNA methyltransferase SPOUT1/CENP-32 links mitotic spindle organization with the neurodevelopmental disorder SpADMiSS
SPOUT1/CENP-32 encodes a putative SPOUT RNA methyltransferase previously identified as a mitotic chromosome associated protein. SPOUT1/CENP-32 depletion leads to centrosome detachment from the spindle poles and chromosome misalignment. Aided by gene matching platforms, here we identify 28 individuals with neurodevelopmental delays from 21 families with bi-allelic variants in SPOUT1/CENP-32 detected by exome/genome sequencing. Zebrafish spout1/cenp-32 mutants show reduction in larval head size with concomitant apoptosis likely associated with altered cell cycle progression. In vivo complementation assays in zebrafish indicate that SPOUT1/CENP-32 missense variants identified in humans are pathogenic. Crystal structure analysis of SPOUT1/CENP-32 reveals that most disease-associated missense variants are located within the catalytic domain. Additionally, SPOUT1/CENP-32 recurrent missense variants show reduced methyltransferase activity in vitro and compromised centrosome tethering to the spindle poles in human cells. Thus, SPOUT1/CENP-32 pathogenic variants cause an autosomal recessive neurodevelopmental disorder: SpADMiSS (SPOUT1 Associated Development delay Microcephaly Seizures Short stature) underpinned by mitotic spindle organization defects and consequent chromosome segregation errors.
- 17 February 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-24
Open AccessRNA methyltransferase SPOUT1/CENP-32 links mitotic spindle organization with the neurodevelopmental disorder SpADMiSS
SPOUT1/CENP-32 encodes a putative SPOUT RNA methyltransferase previously identified as a mitotic chromosome associated protein. SPOUT1/CENP-32 depletion leads to centrosome detachment from the spindle poles and chromosome misalignment. Aided by gene matching platforms, here we identify 28 individuals with neurodevelopmental delays from 21 families with bi-allelic variants in SPOUT1/CENP-32 detected by exome/genome sequencing. Zebrafish spout1/cenp-32 mutants show reduction in larval head size with concomitant apoptosis likely associated with altered cell cycle progression. In vivo complementation assays in zebrafish indicate that SPOUT1/CENP-32 missense variants identified in humans are pathogenic. Crystal structure analysis of SPOUT1/CENP-32 reveals that most disease-associated missense variants are located within the catalytic domain. Additionally, SPOUT1/CENP-32 recurrent missense variants show reduced methyltransferase activity in vitro and compromised centrosome tethering to the spindle poles in human cells. Thus, SPOUT1/CENP-32 pathogenic variants cause an autosomal recessive neurodevelopmental disorder: SpADMiSS (SPOUT1 Associated Development delay Microcephaly Seizures Short stature) underpinned by mitotic spindle organization defects and consequent chromosome segregation errors.
- Open Access
The Utility of Ultra-Deep RNA sequencing in Mendelian Disorder Diagnostics
Clinical RNA-seq has become an essential tool for resolving variants of uncertain significance (VUS), particularly those affecting gene expression and splicing. However, most reference data and diagnostic protocols employ relatively modest sequencing depths (∼50-150 million reads), which may fail to capture low-abundance transcripts and rare splicing events critical for accurate diagnoses. We evaluated the diagnostic and translational utility of ultra-high-depth (up to ∼one billion unique reads) RNA-seq in four clinically accessible tissues (blood, fibroblast, LCL, and iPSC) using Ultima sequencing platform. After validating the performance of Ultima RNA-seq, we investigated how increasing depth affects gene and isoform detection, splicing variant discovery, and clinical interpretation of VUS. Deep RNA-seq substantially improved sensitivity for detecting lowly-expressed genes and isoforms. At ∼1 billion reads, near-saturation was achieved for gene-level detection, although isoform-level coverage continued to benefit from even deeper sequencing. In two clinical cases with VUS, pathogenic splicing abnormalities were undetected at ∼50 million reads but emerged at 200 million reads, becoming even more pronounced at ∼one billion reads. Using deep RNA-seq data, we constructed a novel resource, MRSD-deep, to estimate the minimum required sequencing depth to achieve desired coverage thresholds. MRSD-deep provided gene- and junction-level guidelines, aiding labs in selecting suitable coverage targets for specific applications. Leveraging deep RNA-seq data on fibroblast, we also built an expanded splicing-variation reference that successfully identified rare splicing events missed by standard-depth data. Our findings underscore the diagnostic and research benefits of deep RNA-seq for Mendelian disease investigations. By capturing rare transcripts and splicing events, ultra-high-depth RNA-seq can facilitate more definitive variant interpretations and enrich splicing-reference databases. We anticipate that cost-effective deep sequencing technologies and robust reference cohorts will further advance RNA-based diagnostics in precision medicine.
Open AccessThe Utility of Ultra-Deep RNA sequencing in Mendelian Disorder Diagnostics
Clinical RNA-seq has become an essential tool for resolving variants of uncertain significance (VUS), particularly those affecting gene expression and splicing. However, most reference data and diagnostic protocols employ relatively modest sequencing depths (∼50-150 million reads), which may fail to capture low-abundance transcripts and rare splicing events critical for accurate diagnoses. We evaluated the diagnostic and translational utility of ultra-high-depth (up to ∼one billion unique reads) RNA-seq in four clinically accessible tissues (blood, fibroblast, LCL, and iPSC) using Ultima sequencing platform. After validating the performance of Ultima RNA-seq, we investigated how increasing depth affects gene and isoform detection, splicing variant discovery, and clinical interpretation of VUS. Deep RNA-seq substantially improved sensitivity for detecting lowly-expressed genes and isoforms. At ∼1 billion reads, near-saturation was achieved for gene-level detection, although isoform-level coverage continued to benefit from even deeper sequencing. In two clinical cases with VUS, pathogenic splicing abnormalities were undetected at ∼50 million reads but emerged at 200 million reads, becoming even more pronounced at ∼one billion reads. Using deep RNA-seq data, we constructed a novel resource, MRSD-deep, to estimate the minimum required sequencing depth to achieve desired coverage thresholds. MRSD-deep provided gene- and junction-level guidelines, aiding labs in selecting suitable coverage targets for specific applications. Leveraging deep RNA-seq data on fibroblast, we also built an expanded splicing-variation reference that successfully identified rare splicing events missed by standard-depth data. Our findings underscore the diagnostic and research benefits of deep RNA-seq for Mendelian disease investigations. By capturing rare transcripts and splicing events, ultra-high-depth RNA-seq can facilitate more definitive variant interpretations and enrich splicing-reference databases. We anticipate that cost-effective deep sequencing technologies and robust reference cohorts will further advance RNA-based diagnostics in precision medicine.
- Open Access
- 1 November 2024
- Published by Cold Spring Harbor Laboratory in Genome Research
- Vol. 34 (11) , 1785-1797
Leveraging the T2T assembly to resolve rare and pathogenic inversions in reference genome gaps
Chromosomal inversions (INVs) are particularly challenging to detect due to their copy-number neutral state and association with repetitive regions. Inversions represent about 1/20 of all balanced structural chromosome aberrations and can lead to disease by gene disruption or altering regulatory regions of dosage-sensitive genes incis. Short-read genome sequencing (srGS) can only resolve ∼70% of cytogenetically visible inversions referred to clinical diagnostic laboratories, likely due to breakpoints in repetitive regions. Here, we study 12 inversions by long-read genome sequencing (lrGS) (n= 9) or srGS (n= 3) and resolve nine of them. In four cases, the inversion breakpoint region was missing from at least one of the human reference genomes (GRCh37, GRCh38, T2T-CHM13) and a reference agnostic analysis was needed. One of these cases, an INV9 mappable only in de novo assembled lrGS data using T2T-CHM13 disruptsEHMT1consistent with a Mendelian diagnosis (Kleefstra syndrome 1; MIM#610253). Next, by pairwise comparison between T2T-CHM13, GRCh37, and GRCh38, as well as the chimpanzee and bonobo, we show that hundreds of megabases of sequence are missing from at least one human reference, highlighting that primate genomes contribute to genomic diversity. Aligning population genomic data to these regions indicated that these regions are variable between individuals. Our analysis emphasizes that T2T-CHM13 is necessary to maximize the value of lrGS for optimal inversion detection in clinical diagnostics. These results highlight the importance of leveraging diverse and comprehensive reference genomes to resolve unsolved molecular cases in rare diseases.
- 1 November 2024
- Published by Cold Spring Harbor Laboratory in Genome Research
- Vol. 34 (11) , 1785-1797
Open AccessLeveraging the T2T assembly to resolve rare and pathogenic inversions in reference genome gaps
Chromosomal inversions (INVs) are particularly challenging to detect due to their copy-number neutral state and association with repetitive regions. Inversions represent about 1/20 of all balanced structural chromosome aberrations and can lead to disease by gene disruption or altering regulatory regions of dosage-sensitive genes incis. Short-read genome sequencing (srGS) can only resolve ∼70% of cytogenetically visible inversions referred to clinical diagnostic laboratories, likely due to breakpoints in repetitive regions. Here, we study 12 inversions by long-read genome sequencing (lrGS) (n= 9) or srGS (n= 3) and resolve nine of them. In four cases, the inversion breakpoint region was missing from at least one of the human reference genomes (GRCh37, GRCh38, T2T-CHM13) and a reference agnostic analysis was needed. One of these cases, an INV9 mappable only in de novo assembled lrGS data using T2T-CHM13 disruptsEHMT1consistent with a Mendelian diagnosis (Kleefstra syndrome 1; MIM#610253). Next, by pairwise comparison between T2T-CHM13, GRCh37, and GRCh38, as well as the chimpanzee and bonobo, we show that hundreds of megabases of sequence are missing from at least one human reference, highlighting that primate genomes contribute to genomic diversity. Aligning population genomic data to these regions indicated that these regions are variable between individuals. Our analysis emphasizes that T2T-CHM13 is necessary to maximize the value of lrGS for optimal inversion detection in clinical diagnostics. These results highlight the importance of leveraging diverse and comprehensive reference genomes to resolve unsolved molecular cases in rare diseases.